ALDRIGHETTI, LUCA ANTONIO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 22.527
AS - Asia 21.550
EU - Europa 20.426
SA - Sud America 6.018
Continente sconosciuto - Info sul continente non disponibili 1.608
AF - Africa 507
OC - Oceania 34
AN - Antartide 1
Totale 72.671
Nazione #
US - Stati Uniti d'America 21.117
RU - Federazione Russa 10.872
SG - Singapore 8.187
CN - Cina 5.717
BR - Brasile 4.879
IT - Italia 3.822
HK - Hong Kong 2.738
VN - Vietnam 2.156
SE - Svezia 1.576
FR - Francia 1.018
BD - Bangladesh 1.008
DE - Germania 759
CA - Canada 621
GB - Regno Unito 432
AR - Argentina 407
FI - Finlandia 397
IN - India 350
IE - Irlanda 319
RO - Romania 303
MX - Messico 245
EC - Ecuador 234
AT - Austria 225
ID - Indonesia 212
IQ - Iraq 165
JP - Giappone 153
NL - Olanda 153
ZA - Sudafrica 150
CO - Colombia 131
PL - Polonia 129
ES - Italia 113
TR - Turchia 108
VE - Venezuela 97
PY - Paraguay 95
JM - Giamaica 92
MA - Marocco 89
PK - Pakistan 88
CR - Costa Rica 82
HN - Honduras 80
UA - Ucraina 78
MY - Malesia 76
CL - Cile 75
UZ - Uzbekistan 71
SA - Arabia Saudita 63
EG - Egitto 53
KE - Kenya 51
NI - Nicaragua 50
NP - Nepal 49
AE - Emirati Arabi Uniti 45
TN - Tunisia 45
LT - Lituania 44
PE - Perù 43
TT - Trinidad e Tobago 43
PH - Filippine 41
GT - Guatemala 40
UY - Uruguay 33
AZ - Azerbaigian 32
DZ - Algeria 32
PR - Porto Rico 31
IL - Israele 30
AU - Australia 29
SV - El Salvador 28
DO - Repubblica Dominicana 26
JO - Giordania 26
KR - Corea 26
KZ - Kazakistan 24
CH - Svizzera 23
BH - Bahrain 22
IR - Iran 21
OM - Oman 20
TH - Thailandia 19
BE - Belgio 18
CW - ???statistics.table.value.countryCode.CW??? 17
BB - Barbados 14
BO - Bolivia 14
LB - Libano 14
PA - Panama 14
SC - Seychelles 14
TW - Taiwan 14
AL - Albania 13
BY - Bielorussia 13
GP - Guadalupe 12
GR - Grecia 11
NO - Norvegia 11
SK - Slovacchia (Repubblica Slovacca) 11
A1 - Anonimo 10
BS - Bahamas 10
HU - Ungheria 10
CZ - Repubblica Ceca 9
ET - Etiopia 9
PS - Palestinian Territory 9
RS - Serbia 9
AO - Angola 8
CI - Costa d'Avorio 8
DK - Danimarca 8
KG - Kirghizistan 8
MD - Moldavia 8
SY - Repubblica araba siriana 8
XK - ???statistics.table.value.countryCode.XK??? 8
CG - Congo 7
KH - Cambogia 7
Totale 70.934
Città #
Dallas 3.931
Singapore 3.790
Ashburn 2.853
Hong Kong 2.707
Moscow 2.361
San Jose 2.345
Council Bluffs 1.090
Shanghai 1.083
Milan 1.000
Hefei 986
Ho Chi Minh City 845
Lauterbourg 832
Princeton 751
Lawrence 740
Beijing 624
New York 533
Santa Clara 473
Hanoi 438
Los Angeles 418
Phoenix 376
São Paulo 366
Rome 327
Helsinki 312
Dublin 307
Nuremberg 234
North Bergen 198
Miano 197
Rio de Janeiro 152
Orem 143
Boardman 141
Atlanta 131
Montreal 126
Chicago 118
Naples 118
Munich 117
Warsaw 114
Da Nang 113
Vienna 110
Toronto 103
Brooklyn 101
Tokyo 101
Brasília 98
Belo Horizonte 96
Houston 93
London 90
Bologna 86
Mexico City 85
Frankfurt am Main 82
Curitiba 80
Guayaquil 80
Quito 80
Denver 79
Chennai 77
Guangzhou 77
Buffalo 76
Johannesburg 74
Haiphong 72
Stockholm 72
Campinas 69
Boston 68
San José 68
Tashkent 66
Baghdad 63
Porto Alegre 63
Philadelphia 60
Biên Hòa 59
San Francisco 58
Poplar 57
Seattle 56
Kingston 54
Turin 53
Miami 52
Salvador 52
Guarulhos 51
Amsterdam 49
Mumbai 49
Brescia 48
Manchester 48
Cesano Boscone 46
Managua 46
Washington 45
Memphis 44
Lappeenranta 43
Dhaka 41
Florence 41
Kuala Lumpur 41
Jakarta 39
Nairobi 39
Turku 39
Buenos Aires 38
Santo André 38
Charlotte 37
Fortaleza 37
Palermo 37
Ribeirão Preto 37
Thái Bình 37
Goiânia 36
Hải Dương 36
Tianjin 36
Shenzhen 35
Totale 35.213
Nome #
111In-octreotide SPECT in occult carcinoid tumors 1.419
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 357
Recommendations for laparoscopic liver resection: A report from the second international consensus conference held in morioka 219
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 213
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 212
Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma 199
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 198
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 197
[Conservative treatment of postoperative pancreatic fistula. Role of interventional radiology]. FT Trattamento conservativo della fistola pancreatica postoperatoria. Ruolo della radiologia interventistica 186
. Il trapianto di isole pancreatiche come alternativa alla terapia sostitutiva insulinica intensiva nei pazienti affetti da diabete mellito di tipo 1: l'esperienza dell'Istituto Scientifico San Raffale di Milano 182
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 178
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 177
[Continuous 24-hour intragastric pH monitoring. A new model of interpretation]. FT La pHmetria endogastrica continua sulle 24 ore. Nuovo modello d'interpretazione 176
18 casi di incidentaloma della colecisti: analisi della casistica di un singolo centro 175
An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma 172
"Technological" approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study 170
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 169
A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network meta-analysis 169
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 168
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study 165
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence 165
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy 165
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score 164
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 162
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 161
[Intestinal occlusion in cocaine-packet ingestion]. FT L'occlusione intestinale nella cocaine-packet ingestion 161
[Is the surgical treatment of spontaneous bacterial peritonitis still up-to-date?]. FT Trattare chirurgicamente la peritonite batterica spontanea e ancora attuale? 158
[Impact of preoperative locoregional chemotherapy with fluorodeoxyuridine on the outcome of liver resection]. FT Impatto della chemioterapia locoregionale preoperatoria con fluorodesossiuridina (FUDR) sulla chirurgia resettiva epatica 158
[Advanced age as risk factor in liver resection surgery]. FT L'eta avanzata come fattore di rischio nella chirurgia resettiva epatica 157
Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy 156
30 cases of "two stage hepatectomy” for liver metastases from colorectal cancer: a single centre experience 156
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. FT Fattori prognostici dell'outcome a lungo termine della chirurgia resettiva epatica per metastasi da carcinoma colorettale 156
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma 155
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial 155
Laparoscopic versus open liver resection for large (≥ 5 cm) hepatocellular carcinoma in elderly patients: a multicenter propensity score-matched study 152
[Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. FT Ruolo dei sistemi totalmente impiantabili per accesso vascolare a lungo termine nel trattamento del paziente neoplastico 150
Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma 150
A “cui prodest” evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies 149
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 144
[Hepatic resection of metastasis of colorectal carcinoma: analysis of long-term prognostic factors of outcome]. FT Resezioni epatiche per metastasi da carcinoma colorettale: analisi dei fattori prognostici di outcome a lungo termine 143
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 142
[Multimodal approach to rectal carcinoma with hepatic metastasis]. FT Approccio multimodale al carcinoma del retto con metastasi epatica 142
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 138
A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma 136
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 136
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 135
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 133
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 133
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation 132
The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma 132
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 129
Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma 128
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 128
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors 127
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation 126
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 125
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 125
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 125
Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis: shifting the paradigm? Long-term Outcomes from an International Multicentre Study 124
Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma 124
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions 123
“Biological R2” resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection 122
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 122
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma 122
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 121
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 119
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 119
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 119
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma 118
Indocyanine green (ICG)-guided robotic resection for liver adenoma: combined technologies for precision surgery 118
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 118
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible 117
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial 117
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 117
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE 116
Cornerstones and divergencies in the implementation and use of liver hypertrophy techniques: results from a nationwide survey for the set-up of the prospective registry 116
Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study 116
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 116
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 116
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma 115
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 115
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience 115
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 115
Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases 115
Outcomes of elective liver surgery worldwide: a global, prospective, multicenter, cross-sectional study 114
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 114
Navigator nurse implementation within a fast track program of liver resections: How to improve the healthcare service and perioperative results 114
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance to human islet transplantation 114
A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures 114
Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multicenter Study 113
Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy 113
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome 113
Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies 113
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US 113
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 112
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients 112
Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence 112
Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres 112
Assessment of Textbook Outcome in Laparoscopic and Open Liver Surgery 112
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 112
Totale 15.472
Categoria #
all - tutte 413.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 413.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 0 0 0 153 18 40 59 52 29 15 9 25
2022/20233.701 1.842 578 182 28 50 342 314 199 105 23 23 15
2023/20241.498 39 31 119 95 96 177 55 111 7 95 167 506
2024/202512.456 1.613 325 142 155 267 986 1.642 1.081 2.370 1.904 875 1.096
2025/202642.383 2.611 3.697 4.689 6.017 2.787 1.098 3.288 2.724 10.072 2.380 1.416 1.604
2026/202711.544 1.689 2.698 2.753 4.404 0 0 0 0 0 0 0 0
Totale 72.671